Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Quintiles central laboratory receives CAP 15189 accreditation
The lab was accredited for being one of a limited number of central labs in the US to meet the rigorous requirements for medical laboratory quality, and competence
The lab was accredited for being one of a limited number of central labs in the US to meet the rigorous requirements for medical laboratory quality, and competence
The new patent application titled ‘Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer’ gives additional intellectual property protection to the seven antigens used in Immunovaccine’s DPX-0907
Scarguard Labs is a pharmaceutical company specialising in dermatological medications employing an internationally patented delivery system designed to enhance drug effectiveness utilising a multi-technology approach. Scarguard Labs chairman
The integration of DNA shearing technology with automation and microfluidics solutions simplifies next generation sequencing workflows and improves sample quality. Covaris sample preparation technology, which is based on
The Phase 3 trial evaluating the safety and efficacy of rFXIII has showed positive results when compared to a historic control group of individuals who did not receive
The European Commission Directive, which has already been adopted in the UK, permits the use of existing additives such as polyvinyl alcohol (PVA) and six grades of polyethylene
The new product is incorporated in the company’s proprietary delivery system which allows the peptides to penetrate the skin and be delivered to the desired layers, making it
GE featured remote access to its portfolio of electronic medical records (EMRs) for physician practices, including Centricity Advance and Centricity Practice Solution, on the Apple iPad and iPhone.
Discovered by Takeda, the compound is indicated for the treatment of hypertension, or high blood pressure. Azilsartan medoxomil is an angiotensin II receptor blocker (ARB) which lowers blood
euSEND brings together universities, pharma firms, other international research organizations and product development partnerships to encourage development of solutions for neglected tropical diseases. The Dutch initiative builds, amongst